PaxMedica, Common Stock Valuation
| PXMDDelisted Stock | USD 0.86 0.18 17.31% |
Today, the company appears to be overvalued. PaxMedica, Common Stock holds a recent Real Value of $0.82 per share. The prevailing price of the company is $0.86. Our model determines the value of PaxMedica, Common Stock from analyzing the company fundamentals such as Shares Owned By Institutions of 1.60 %, return on equity of -10.47, and Shares Outstanding of 7.47 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that PaxMedica, Common's price fluctuation is very steady at this time. Calculation of the real value of PaxMedica, Common Stock is based on 3 months time horizon. Increasing PaxMedica, Common's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PaxMedica, pink sheet is determined by what a typical buyer is willing to pay for full or partial control of PaxMedica, Common Stock. Since PaxMedica, Common is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PaxMedica, Pink Sheet. However, PaxMedica, Common's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.86 | Real 0.82 | Hype 0.86 | Naive 0.82 |
The real value of PaxMedica, Pink Sheet, also known as its intrinsic value, is the underlying worth of PaxMedica, Common Stock Company, which is reflected in its stock price. It is based on PaxMedica, Common's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PaxMedica, Common's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PaxMedica, Common Stock helps investors to forecast how PaxMedica, pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PaxMedica, Common more accurately as focusing exclusively on PaxMedica, Common's fundamentals will not take into account other important factors: PaxMedica, Common Total Value Analysis
PaxMedica, Common Stock is at this time expected to have valuation of 388.33 K with market capitalization of 5.14 M, debt of 173.54 K, and cash on hands of 9.06 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PaxMedica, Common fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
388.33 K | 5.14 M | 173.54 K | 9.06 K |
PaxMedica, Common Asset Utilization
One of the ways to look at asset utilization of PaxMedica, is to check how much profit was generated for every dollar of assets it reports. PaxMedica, Common holds a negative application of assets of -2.56 pct., losing $0.0256 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of PaxMedica, Common Stock shows how discouraging it operates for each dollar spent on its assets.PaxMedica, Common Ownership Allocation
PaxMedica, Common holds 8.14 pct. of its outstanding shares held by insiders and 1.6 pct. owned by third-party entities.PaxMedica, Common Profitability Analysis
Net Loss for the year was (18.29 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PaxMedica, Common's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PaxMedica, Common and how it compares across the competition.
About PaxMedica, Common Valuation
The pink sheet valuation mechanism determines PaxMedica, Common's current worth on a weekly basis. Our valuation model uses a comparative analysis of PaxMedica, Common. We calculate exposure to PaxMedica, Common's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PaxMedica, Common's related companies.PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC. Paxmedica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people.
8 Steps to conduct PaxMedica, Common's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates PaxMedica, Common's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct PaxMedica, Common's valuation analysis, follow these 8 steps:- Gather financial information: Obtain PaxMedica, Common's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine PaxMedica, Common's revenue streams: Identify PaxMedica, Common's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research PaxMedica, Common's industry and market trends, including the size of the market, growth rate, and competition.
- Establish PaxMedica, Common's growth potential: Evaluate PaxMedica, Common's management, business model, and growth potential.
- Determine PaxMedica, Common's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate PaxMedica, Common's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
PaxMedica, Common Growth Indicators
Investing in growth stocks can be very risky. If the company such as PaxMedica, Common does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.7 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in PaxMedica, Pink Sheet
If you are still planning to invest in PaxMedica, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PaxMedica, Common's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |